Dallas biotech

OncoNano Taps Veteran Biopharmaceutical Leader as Its New Chief Operating Officer

by | Nov 20, 2025
With more than two decades of experience in product development, strategic operations, and commercial execution across the biotechnology industry, Brent Sorrells will help drive OncoNano’s next phase of growth and operational excellence, the company said.
MORE
Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles
by | Aug 20, 2025
With just 2% to 6% of small-molecule drugs able to cross the blood-brain barrier, researchers and drugmakers face steep odds. Lantern Pharma’s tool, the company’s CEO says, could be “a paradigm shift” in developing treatments for conditions ranging from brain cancers to Parkinson’s disease.
MORE
See Inside: BioLabs Coworking Lab Opens at Pegasus Park for North Texas Life Science Startups
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.

BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE
Gates Foundation Scientist Joins Dallas Philanthropist to Talk Status of COVID-19 Vaccine—and Biotech in DFW
Dr. Lynda Stuart of the Bill & Melinda Gates Foundation talked with philanthropist and entrepreneur Lyda Hill in a virtual discussion moderated by Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies.

Here's the takeaway.
MORE
R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Dallas Gene Therapy Startup Closes $95M Series B to Bolster its Initial Clinical Studies
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE